Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 130/0.4 versus acetated Ringer's solution for volume expansion during CABG induction
ChiCTR-TRC-11001608Phase 4Completed
- Sponsor
- Department of Anesthesiology, First Affiliated Hospital, China Medical University
- Start
- Mar 2011
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Volulyte and ringer's acetate in coronary arteriosclerosis (3 arms), sponsored by Department of Anesthesiology, First Affiliated Hospital, China Medical University. Primary endpoint: Hemodynamic parameters. Started Mar 2011; status: completed.
02
Drugs
Volulyteringer's acetate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001608.